research:angioedema
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
|
research:angioedema [2016/05/03 14:55] jduke |
research:angioedema [2016/05/18 16:21] jduke |
||
|---|---|---|---|
| Line 18: | Line 18: | ||
| **Participating Institution(s):** Regenstrief Institute, Janssen Research and Development, Columbia University, University of California, Los Angeles | **Participating Institution(s):** Regenstrief Institute, Janssen Research and Development, Columbia University, University of California, Los Angeles | ||
| - | **Full Protocol:** [[https://drive.google.com/open?id=0BxVdB7jYnXcDTDQ4OGhsM1dKaHM|Keppra and Angioedema Risk Protocol]] | + | **Full Protocol:** [[https://drive.google.com/file/d/0BzotZ5gIRvegT3Y5djBOUldzaVE/view?usp=sharing|Keppra and Angioedema Risk Protocol]] |
| **Initial Proposal Date:** 5/3/2016 | **Initial Proposal Date:** 5/3/2016 | ||
| - | **Launch Date:** TBD | + | **Launch Date:** 5/18/2016 |
| - | **Receive Results for Analysis Date:** TBD | + | **Receive Results for Analysis Date:** 7/15/2016 |
| **Study Closure Date:** TBD | **Study Closure Date:** TBD | ||
| - | **Results Submission:** [[mailto:jonduke@regenstrief.org|Email]] or SFTP | + | **Results Submission:** Via the OHDSI Sharing module embedded in study or via [[mailto:jonduke@regenstrief.org|Email]]. |
| </WRAP> | </WRAP> | ||
| Line 34: | Line 34: | ||
| ===== Requirements ===== | ===== Requirements ===== | ||
| - | **CDM:** V4 or V5 | + | **CDM:** V5 only |
| **Table Accessed:** CONCEPT, CONCEPT_ANCESTOR, CONDITION_ERA, CONDITION_OCCURRENCE, DRUG_ERA, DRUG_EXPOSURE, MEASUREMENT, OBSERVATION, OBSERVATION_PERIOD, PERSON, PROCEDURE_OCCURRENCE, VISIT_OCCURRENCE | **Table Accessed:** CONCEPT, CONCEPT_ANCESTOR, CONDITION_ERA, CONDITION_OCCURRENCE, DRUG_ERA, DRUG_EXPOSURE, MEASUREMENT, OBSERVATION, OBSERVATION_PERIOD, PERSON, PROCEDURE_OCCURRENCE, VISIT_OCCURRENCE | ||
| Line 40: | Line 40: | ||
| **Database Dialects:** SQL Server, Postgres, Oracle | **Database Dialects:** SQL Server, Postgres, Oracle | ||
| - | **Software:** SQL and R | + | **Software:** R (v 3.2.2, RTools), Java |
| + | |||
| + | **Hardware:** Recommended 8-core, 32GB memory, 100GB free space | ||
| ===== Code ===== | ===== Code ===== | ||
| - | [[https://github.com/ohdsi|GitHub code for Proposed Study - Keppra and Angioedema Risk]] | + | [[https://github.com/OHDSI/StudyProtocols/tree/master/KeppraAngioedema|GitHub code for Proposed Study - Keppra and Angioedema Risk]] |
| ===== Discussion ===== | ===== Discussion ===== | ||
| Line 50: | Line 53: | ||
| ===== Datasets Run ===== | ===== Datasets Run ===== | ||
| + | * IMEDS lab | ||
| * | * | ||
| ===== Waiting for Datasets From ===== | ===== Waiting for Datasets From ===== | ||
| - | * | + | * Regenstrief (INPC) |
| + | * Columbia University | ||
| ~~NOTOC~~ | ~~NOTOC~~ | ||
research/angioedema.txt · Last modified: 2017/12/14 05:54 by schuemie
Page Tools
